Skip to main content
Erschienen in: Pediatric Nephrology 10/2010

Open Access 01.10.2010 | Original Article

Peritonitis in children on peritoneal dialysis in Cape Town, South Africa: epidemiology and risks

verfasst von: Renske Raaijmakers, Priya Gajjar, Cornelis Schröder, Peter Nourse

Erschienen in: Pediatric Nephrology | Ausgabe 10/2010

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Peritonitis is a frequent complication of peritoneal dialysis (PD) in children as well in adults. Data on PD and peritonitis in pediatric patients are very scarce in developing countries. A retrospective cohort study was performed between 2000 and 2008 with the aim to evaluate PD treatment and peritonitis epidemiology in pediatric patients in South Africa and identify risk factors for peritonitis. Baseline characteristics and potential risk factors of peritonitis were recorded, including housing, socio-economic circumstances, distance to PD center, type of PD, mode of catheter placement, race, presence of gastrostomy tube, weight, and height. Outcome indices for peritonitis were peritonitis rate, time to first peritonitis, and number of peritonitis-free patients. The patient cohort comprised 67 patients who were on PD for a total of 544 months. The total number of peritonitis episodes was 129. Median peritonitis rate was one episode every 4.3 patient months (2.8 episodes/patient-year, range 0–21.2). Median time to first infection was 2.03 months (range 0.1–21.5 months), and 28.4% of patients remained free from peritonitis. Patients with good housing and good socio-economic circumstances had a significantly lower peritonitis rate and a longer time to first peritonitis episode. Peritonitis rate was high in this cohort, compared to numbers reported for the developed world; the characteristics of causative organisms are comparable. The most important risk factors for the development of peritonitis were poor housing and poor socio-economic circumstances. More intensive counseling may be beneficial, but improvement of general socio-economic circumstances will have the greatest influence on PD success.

Introduction

Frequently occurring diseases in developing countries, such as acquired immunodeficiency syndrome (AIDS), tuberculosis, malaria, gastro-enteritis, and hypertension are often complicated by renal diseases [1]. No reliable statistics are available on causes of end-stage renal disease (ESRD); the only data available are those from dialysis and transplantation, but these databases represent a selection of patients based on eligibility for transplantation as well as those with access to renal replacement therapy. The reported prevalence of patients with ESRD in Africa in 2004 was 70/million population, and the prevalence of renal replacement therapy (RRT) was 65/million population. The global prevalence in 2004 for ESRD was 280/million population, with a prevalence of RRT of 215/million population [2]. These numbers clearly reflect an under-reporting of ESRD in Africa together with a shortage of renal replacement therapy. In recent years, peritoneal dialysis (PD) has become increasingly available in developing countries. PD has been described as the dialysis technique of choice in developing countries, where mass poverty and poor resources play an important role in health care [3]. PD can be performed at a relatively low cost as it is less reliant than other dialysis techniques on expensive infrastructure and health professionals. Also, because it is a home-based technique, there are savings on travel expenses. In developing countries, PD is becoming increasingly available as a renal replacement modality. In 2004, the worldwide growth was 11% in countries other than Europe, the USA or Japan, where no growth was observed [2]. In developing countries, dialysis patients tend to be of a younger age than in developed countries [2].
The first reported experiences with PD in South Africa originate from the 1980s [4, 5]. These early attempts were successful, but multiple problems were encountered which restricted the success rate. The most important of these were a lack of transportation, poor housing and sanitation, inadequate education, and poor acceptance of therapy.
Peritonitis is a frequent complication of PD in both children and adults. Peritonitis characteristics in children vary highly over the world, influenced by geographical and socio-economic differences, among other factors [6].
Data on PD and peritonitis in pediatric patients in developing countries are scarce. In the study reported here, we evaluated the epidemiology of peritonitis in children on PD in Cape Town, South Africa and identified potential risk factors for peritonitis.

Materials and Methods

Ethics

The study was approved by the hospital ethics committee.

Study design

A retrospective clinical cohort study was carried out at the Red Cross Children’s Hospital in Cape Town, South Africa. The Red Cross Children’s Hospital is one of two university hospitals in South Africa where pediatric PD is performed. Only patients considered to be eligible for transplantation are accepted into the dialysis program. Data on all patients aged from 0 to 18 years enrolled in the PD program between 2000 and 2008 were analyzed.

Patients

The patient cohort comprised 67 patients (35 males, 32 females) who were treated with PD for a total of 544 months. Median age at the start of the PD treatment was 10.1 years (range 1.2–17.4 years). The age distribution of the patients is given in Fig. 1. Median time on PD was 7.0 months (range 0.4–36.8 months). All patients were on PD due to ESRD. Underlying diseases were glomerulonephritis (24%), dysplastic kidneys (16%), focal segmental glomerulosclerosis (13%), reflux nephropathy (9%), nephrotic syndrome (5%), urethral valves (5%), hemolytic uremic syndrome (3%), unknown (12%), and other diseases (13%; nephronopthisis, primary hyperoxaluria, cystinosis, Alport, systemic lupus erythematosus, infection). All patients in this cohort had single-cuff, upward-pointing, straight catheters for dialysis, as this type of catheter is preferred by the local surgeons due to it being easier to remove if necessary. The same type of catheter was used in all patients to achieve maximum routine and, hence, a smaller risk of operation-related complications. Omentectomy was performed as a routine where possible. When not in use (2-week periods), catheters were secured to the abdomen and not redressed during this time. Antibiotics were not routinely given at time of placement.
Training on exit-site care was provided standard for all patients. Nurses teach patients and parents about exit-site care, including dressing and general hygiene. All peritonitis episodes were primarily treated according to the local protocol with cefotaxime and vancomycin intraperitoneally. Treatment was individualized once culture results were available.

Methods

Demographic and biomedical data were obtained by evaluating the patients’ medical records. Socio-economic data were clinically evaluated by a clinical social worker and the pediatric nephrologist taking care of the patient. Patient baseline characteristics, patient survival, technique survival, and all episodes of peritonitis were analyzed. For each peritonitis episode, the causative organism, occurrence of a Gram-negative or fungal infection (noted as severe infection because of the relative high risk of catheter removal, technique failure, and relapse [79]), occurrence of technique failure because of peritonitis, and survival after peritonitis were recorded.
The following primary peritonitis outcome indices were assessed: (1) peritonitis rate (expressed as one peritonitis episode every x patient-month and as number of episodes/patient-year); (2) peritonitis-free period (time to first peritonitis episode); (3) peritonitis-free patients [patients not suffering from peritonitis vs. all patients that suffered from one or more peritonitis episodes and vs. the 25% of the patients with the highest rate of peritonitis (rate >0.4/patient month)]. The occurrence of peritonitis was diagnosed by a pediatric nephrologist. Patients were considered to have peritonitis when two of the following criteria were present: abdominal pain, cloudy dialysis fluid, leukocyte count >100/mm3, and/or positive culture of dialysis fluid. An infection with the same causative organism as that in the immediately preceding episode (based on culture results and antibiotic susceptibilities) within 4 weeks after completion of the first antibiotic treatment was considered as a recurrent peritonitis and was not included in our data as a new peritonitis episode. Possible risk factors were assessed in all patients: age of the patient (in months); weight and height (both expressed as: good >10th percentile; fair 3rd to 10th percentile; poor <3rd percentile); type of PD [continuous ambulatory PD (CAPD) vs. nightly intermittent PD (NIPD)]; mode of catheter placement (laparoscopic vs. laparotomic); distance to PD center (more or less than 200 km); presence of gastrostomy tube; race (black vs. black mixed with other races vs. white); housing; socio-economic circumstances. The assessment of housing was based on three criteria, namely, the availability of electricity, running water, and adequate sanitation with bathroom facilities, respectively. Housing was classified as good when electricity, running water, and bathroom facilities were all available, as fair when any one of these three criteria was missing, and as poor when two or more of these three criteria were missing. Institutional housing (in hospital or clinical care center) was classified as a separate category. Criteria for the assessment of socio-economic circumstances were: (1) one or two parents/care-givers present; (2) employment of care-givers; (3) availability of adequate social support in and around the family. Socio-economic circumstances were classified as good when two parents/care-givers were present, one or both care-givers were employed, and an adequate social network was in place. They were classified as fair when any one of the above three criteria was suboptimal (e.g. only one care-giver present or unemployment of care-givers or inadequate social network) and as poor when two or more of the above three criteria were suboptimal.

Statistical analysis

Variables were not distributed normally, therefore results were expressed as medians, ranges, and percentages, and outcome indices were assessed with non-parametric tests and with different types of tests to improve the robustness of the statistical analysis. Spearman‘s correlation coefficient was calculated for the continuous risk factor, age. Differences between categorical dichotomous risk factors (type of PD, catheter placement, and distance to PD center) were tested with the Mann–Whitney U test. For categorical risk factors with more than two categories (for the risk factors weight, height, housing and socio-economic circumstances), both the Kruskal–Wallis test as well as the Mann–Whitney U test were performed, whereby with the Mann–Whitney U test the category ‘good’ was tested against the other categories. For the risk factor ‘race’, black, mixed, and white race were tested separately with the Kruskal–Wallis test as well as combined (black/mixed vs. white) with the Mann Whitney–U test. For the outcome variable ‘time to first peritonitis’, peritonitis episodes without an exact time indication and peritonitis-free patients were excluded. The outcome variable ‘peritonitis-free patients’ was tested dichotomously with chi-square tests. For statistically significant risk factors, the degree of correlation was tested with linear backward regression with multicollinearity diagnostics. Collinearity diagnostics give an estimation of the independent effect of specific risk factors, and the degree of collinearity is a measure for the correlation between risk factors. Kaplan–Meier hazard regression analysis was used for the cumulative risk of developing a first infection, according to Vonesh et al. [10]. This analysis compared the relative probability of developing a first infection between subgroups of the study population. Differences were considered significant at p values <0.05.

Results

During the total treatment period of 544 months, 129 peritonitis episodes occurred. The median peritonitis rate was one episode every 4.3 patient-months, or 2.8 episodes per patient-year (range 0–21.2). The distribution of the peritonitis rate over the total patient group is shown in Fig. 2. Median time from initiation of PD to first peritonitis was 2.03 months (range 0.1–21.5 months). Eleven patients experienced their first peritonitis episode within the first month on PD, and 19 patients (28.4%) remained free from peritonitis. Median time on dialysis was 7.0 months. Classification of the peritonitis episodes according to causative organism is shown in Table 1. In 10% of the cultures, the causative organism remained unclassified and could not be identified in the respective patients. Eleven patients developed a fungal peritonitis (14.9% of all patients, 7.7% of all peritonitis episodes). Of these patients, 91% had suffered from one or more bacterial peritonitis episodes prior to the fungal peritonitis episode. The fungal peritonitis patients also experienced a significantly higher number of peritonitis episodes (p = 0.001), a significantly higher peritonitis incidence (p = 0.006), and a higher rate of technique failure (p = 0.0001) compared to the other patients. One patient developed a tuberculous peritonitis, with good clinical outcome. Patient survival on peritoneal dialysis was 100%. Technique failure with a temporary switch to hemodialysis occurred in 11 patients (16.4%) and was significantly higher in patients with a higher peritonitis rate (p = 0.001). Fifty-three patients (79.1%) were transplanted.
Table 1
Classification of causative organisms
Causative agents
Number of peritonitis episodes
Percentage
Gram-positive
39
30.2
Gram-negative
29 (+1)a
23.3
Fungal
9 (+1)a
7.7
Mycobacterium tuberculosis
1
0.8
Fungal and Gram-negative
1a
0.8
Culture-negative
37
28.7
Unknown
13
10.1
Total
129
100
aA fungus and a Gram-negative organism were both cultured in one culture
All potential risk factors for the peritonitis indices were analyzed. No correlation was found between age and peritonitis incidence (Spearman’s correlation coefficient −0.009, p = 0.94) or between age and peritonitis-free period (Spearman’s correlation coefficient 0.14, p = 0.42). Our analysis of all dichotomous risk factors is shown in Tables 2 and 3. With good housing, peritonitis incidence was significantly lower (p = 0.03) and the peritonitis-free period longer, nearly reaching significance (p = 0.052), compared to fair and poor housing. When all types of housing were tested separately by the Kruskal–Wallis test, small numbers of patients were present in each subgroup, and these results did not reach significance (data not shown). When good socio-economic circumstances were compared to fair and poor socio-economic circumstances, the peritonitis rate was significantly lower (p = 0.02) and time to first peritonitis was longer (p2= 0.01). These results remained statistically significant when all three socio-economic categories were tested separately with the Kruskal–Wallis test, despite relatively small numbers in each subgroup, with p values of 0.006 and 0.03 for peritonitis incidence and time to first peritonitis, respectively (Table 4).
Table 2
Mann–Whitney U test for potential risk factors
Potential risk factors
Peritonitis rate: peritonitis/patient-year
Peritonitis-free period: time to first peritonitis episode (months)
Median
Range
p
Median
Range
p
Distance to PD center >200 km
2.81
0-21.2
0.39
2.7
0.33-21.5
0.15
Distance to PD center <200 km
2.49
0-9.2
1.8
0-8.9
Type of PD: NIPD
2.83
0-17.6
0.75
2.2
0.07-21.5
0.18
Type of PD: CAPD
1.99
0-7.45
1.8
0-5.73
Catheter placement laparoscopic
2.94
0-21.2
0.36
2.2
0-8.9
0.73
Catheter placement open
2.69
0-9.20
1.8
0.87-2.8
Weight good
2.02
0-17.6
0.47
1.8
0.43-2.83
0.21
Weight fair/poor
2.86
0-21.2
2.2
0-21.5
Height good
2.56
0-17.6
0.51
1.23
0.43-2.83
0.60
Height fair/poor
2.76
0-21.2
2.03
0-21.5
Housing good
2.21
0-7.56
0.03
2.52
0.37-21.5
0.052
Housing fair/poor/ institutional
3.86
0-21.2
1.37
0-8.87
Socio-economic circumstances good
1.91
0-17.6
0.02
2.83
0.43-21.5
0.01
Socio-economic circumstances fair/poor
3.88
0-21.2
1.35
0-8.87
Race black/mixed
2.81
0-21.2
0.27
1.8
0.1-8.87
0.085
Race white
1.13
0-5.71
6.97
2.83-21.47
Gastrostomy tube no
2.69
0-21.2
0.45
2.07
0-21.47
0.97
Gastrostomy tube yes
4.46
2-5.71
1.8
0.5-6.97
PD, Peritoneal dialysis; NIPD, nightly intermittent peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis
Table 3
Chi-square test for potential risk factors: peritonitis-free patients versus all patients with peritonitis and peritonitis-free patients versus patients with the highest rate of peritonitis
Risk factors
Peritonitis Yes vs. No peritonitis
Peritonitis High rate vs. No peritonitis
Yes
No
p
High rate
No
p
Distance to PD center >200 km
28
9
0.42
12
9
0.10
Distance to PD center <200 km
20
10
4
10
Type of PD: NIPD
32
9
0.18
11
9
0.14
Type of PD: CAPD
13
8
3
8
Catheter placement laparoscopic
18
6
0.57
7
6
0.67
Catheter placement open
10
5
4
5
Weight good
11
8
0.12
5
8
0.51
Weight fair/poor
37
11
11
11
Height good
9
7
0.12
4
7
0.45
Height fair/poor
39
12
12
12
Housing good
24
14
0.08
5
14
0.01
Housing fair/poor/institutional
24
4
11
4
Socio-economic circumstances good
21
13
0.07
5
13
0.03
Socio-economic circumstances fair/poor
27
6
11
6
Race black/mixed
45
16
0.51
11
16
0.8
Race white
3
2
1
2
Gastrostomy no
43
18
0.67
14
18
0.45
Gastrostomy yes
5
1
2
1
Table 4
Kruskal–Wallis test for socio-economic circumstances
Socio-economic circumstances
Peritonitis rate: peritonitis/patient year
Peritonitis-free period: time to first peritonitis episode
Median (number of patients)
Range
p
Median (number of patients)
Range
p
Socio-economic circumstances good
1.91 (34)
0–17.6
0.006
2.83 (14)
0.43–21.5
0.03
Socio-economic circumstances fair
2.94 (22)
0–9.20
1.80 (11)
0.10–8.87
Socio-economic circumstances poor
4.86 (11)
1.99–21.2
0.87 (9)
0.10–2.77
The statistically significant risk factors housing and socio-economic circumstances were positively correlated, but collinearity was sufficiently low (variance inflation factor 1.28, tolerance 0.78), so the degree of correlation was not considered to be a bias factor in the analysis.
Peritonitis-free patients had significantly better housing and social circumstances than patients with the highest rate of peritonitis.
The cumulative hazard for having a first peritonitis was evaluated for 53 patients (excluding the patients for whom the exact time of the first peritonitis episode was unknown). Patients with good socio-economic circumstances had a significantly lower cumulative hazard than those with fair and poor socio-economic circumstances (p = 0.003) (Fig. 3). Patients with good housing also had a lower cumulative hazard for developing a first peritonitis compared to fair and poor housing (p = 0.001) (Fig. 4). For the combined risk factors housing and socio-economic circumstances, the same trend was seen, but it was even more pronounced (p < 0.0001) (Fig. 5).

Discussion

In this study, an overview of peritoneal dialysis and peritonitis in pediatric patients in Cape Town, South Africa is given, the epidemiology of peritonitis is evaluated, and risk factors are identified. Among our patients, socio-economic circumstances and quality of housing significantly influenced the peritonitis rate, and socio-economic circumstances also significantly influenced time to first peritonitis episode. When both socio-economic circumstances and housing were fair or poor, the cumulative risk to develop peritonitis was even more elevated than that for the separate categories alone. The higher risk group for housing includes the subgroup ‘institutional housing’. The poor results in this group were most likely due suboptimal PD care due to nursing staff shortages, especially in the clinical care center where children were not well supervised or supervised by inexperienced staff. Children only go to this clinical care center when the situation at home is considered too unfavorable to perform dialysis, so this may reflect a pre-selection bias in this subgroup. Socio-economic risk factors have been investigated in only a few adult PD studies [3, 11]. In a South African study by Zent et al. [11], poor socio-economic status (SES) and inadequate housing (high occupants-to-bedroom ratio, no electricity), alcohol abuse, and psychiatric disease were found to be associated with higher peritonitis rates. Black race was also associated with higher peritonitis rates in the study by Zent, but this reflected merely the poorer socio-economic conditions of this population group. In our study, the large majority of our patients were black or black mixed with other races, and no influence of race on peritonitis rate was found. In another South African study, Katz et al. [3] were unable to confirm a relationship between socio-economic parameters and peritonitis rate: education, employment status, home conditions, and earnings did not influence peritonitis and technique failure in their study. Two pediatric studies have also examined socio-economic risk factors in PD. The study by Grunberg et al. [12], performed in Uruguay, showed no differences in patient and technique survival due to SES, while Ariza et al. [13] reported a higher peritonitis rate for Venezuelan pediatric patients with lower SES.
Socio-economic circumstances can be assessed in many ways, and it is a challenge to obtain an objective and adequate mode of measurement that neither loses clarity because of too many details nor loses important information by fitting data into a simplified model. The above-mentioned studies all used an equivalent of the same criteria that we used in our study, with classifications based on education/employment, housing, social support, and family income. Grunberg et al. and Ariza et al. used a modification of an old scoring system, called the ‘Graffar’ score [14], which divides SES into categories based on parents’ education, parents’ educational level, and family source of income. A possible flaw in our study is the absence of a criterion on family income, but inadequate data were available to include this in our classification of socio-economic circumstances.
For the other potential risk factors that were analyzed in this study, we did not find a statistical relationship with peritonitis outcome indices. Distance to the PD center did not influence peritonitis rates in our study, neither did it in the study of Grunberg et al. [12]. Younger age has been identified as a possible risk factor for adults as well as children [11, 1517], but this association was not found in our study. In our patients, no relationship was found between catheter insertion technique or type of PD and peritonitis outcome. In a large systematic review of randomized controlled trials by Strippoli et al. [18], statistically significant differences in peritonitis rates with catheter type or catheter insertion technique were also not found. A possible bias in the epidemiology of our PD population is the fact that only patients eligible for transplantation were included in the dialysis program, influencing, in particular, the time on PD, which was relatively short in our study due to a high transplantation rate.
Peritonitis rates in general were high in our patient group, namely, 2.8 episodes/patient-year, compared to those reported in other pediatric studies. This is especially true if we compare our rate to those reported in studies from developed countries, such as Japan, with 0.29 episodes/patient-year [19], the USA, with 0.19–0.91 episodes/patient-year [16, 20], and Europe, with 0.71–1.1 episodes/patient-year [7, 15, 17]. Compared to studies from South America, where 1.3–2.1 episodes/patient-year have been reported [12, 13], our peritonitis rates are also still relatively high. Worse socio-economic circumstances in developing countries with poor hygiene provide a clear explanation for these differences. Cultural factors also probably play a role when one region is compared to another. The pattern of causative organisms in other studies comprised 44–64% Gram-positive infections, 14–25% Gram-negative infections, 2–7% fungal infections, and 14–31% cultures remaining negative [7, 16, 19, 21]. These percentages are rather comparable to those in our study. The rather low percentage of Gram-positive infections, however, is probably an underestimation due to the relative high percentage of culture-negative peritonitis episodes and the percentage of unknown cultures (10%). The percentage of peritonitis episodes due to unknown organisms and that of the culture-negative peritonitis episodes adds up to 39%, indicating that the percentage of peritonitis episodes for which no specific information about a causative organism was available is particularly high in our study. The fact that in all these cases only empiric treatment was given may help to explain the high incidence of fungal peritonitis. Another explanation for the high percentage of fungal peritonitis is the overall high peritonitis rate and the relative high rate of Gram-negative infections, both of which can be considered to be a risk factor for fungal peritonitis [7, 8]. One patient in this study was diagnosed with peritonitis caused by Mycobacterium tuberculosis. Mycobacterium infections rates are increasing worldwide, and dialysis patients are at higher risk of acquiring mycobacterial infections due to impaired cellular immunity associated with chronic renal failure [22]. Only two cases of tuberculous peritonitis in children on PD have been reported prior to our study [23]. Since tuberculous peritonitis is difficult to diagnose, the actual rates could very well be higher than reported. A more extensive evaluation of culture-negative peritonitis and peritonitis resistant to antibiotic treatment could reveal more cases.
In conclusion, PD is an important modality for renal replacement therapy, especially in developing countries, where the use of PD has been expanding in recent years. Poor socio-economic circumstances play an important role in these societies and influence the peritonitis rate and the success rate of PD. More intensive social counseling and education can hopefully decrease infection rates and rates of PD failure, but an improvement in general socio-economic circumstances will be the factor with the greatest influence on PD success.

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Open AccessThis is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://​creativecommons.​org/​licenses/​by-nc/​2.​0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Pädiatrie

Kombi-Abonnement

Mit e.Med Pädiatrie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Pädiatrie, den Premium-Inhalten der pädiatrischen Fachzeitschriften, inklusive einer gedruckten Pädiatrie-Zeitschrift Ihrer Wahl.

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Literatur
1.
Zurück zum Zitat Naicker S (2003) End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl 83:S119-S122 Naicker S (2003) End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl 83:S119-S122
2.
Zurück zum Zitat Grassmann A, Gioberge S, Moeller S, Brown G (2005) ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20:2587–2593CrossRefPubMed Grassmann A, Gioberge S, Moeller S, Brown G (2005) ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant 20:2587–2593CrossRefPubMed
3.
Zurück zum Zitat Katz IJ, Sofianou L, Hopley M (2001) An African community-based chronic ambulatory peritoneal dialysis programme. Nephrol Dial Transplant 16:2395–2400CrossRefPubMed Katz IJ, Sofianou L, Hopley M (2001) An African community-based chronic ambulatory peritoneal dialysis programme. Nephrol Dial Transplant 16:2395–2400CrossRefPubMed
4.
Zurück zum Zitat Di Bisceglie AM, Mzamane DV (1983) Continuous peritoneal dialysis in a developing population-problems seen at Baragwanath Hospital. S Afr Med J 63:405–406PubMed Di Bisceglie AM, Mzamane DV (1983) Continuous peritoneal dialysis in a developing population-problems seen at Baragwanath Hospital. S Afr Med J 63:405–406PubMed
5.
Zurück zum Zitat Seedat YK (1984) Continuous ambulatory peritoneal dialysis in South Africa. S Afr Med J 65:229–230PubMed Seedat YK (1984) Continuous ambulatory peritoneal dialysis in South Africa. S Afr Med J 65:229–230PubMed
6.
Zurück zum Zitat Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, Mir S, Ha IS, Fischbach M, Simkova E, Watson AR, Moller K, von Baum H, Warady BA (2007) Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 72:1374–1379CrossRefPubMed Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, Mir S, Ha IS, Fischbach M, Simkova E, Watson AR, Moller K, von Baum H, Warady BA (2007) Worldwide variation of dialysis-associated peritonitis in children. Kidney Int 72:1374–1379CrossRefPubMed
7.
Zurück zum Zitat Raaijmakers R, Schroder C, Monnens L, Cornelissen E, Warris A (2007) Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol 22:288–293CrossRefPubMed Raaijmakers R, Schroder C, Monnens L, Cornelissen E, Warris A (2007) Fungal peritonitis in children on peritoneal dialysis. Pediatr Nephrol 22:288–293CrossRefPubMed
8.
Zurück zum Zitat Warady BA, Bashir M, Donaldson LA (2000) Fungal peritonitis in children receiving peritoneal dialysis: A report of the NAPRTCS. Kidney Int 58:384–389CrossRefPubMed Warady BA, Bashir M, Donaldson LA (2000) Fungal peritonitis in children receiving peritoneal dialysis: A report of the NAPRTCS. Kidney Int 58:384–389CrossRefPubMed
9.
Zurück zum Zitat Zurowska A, Feneberg R, Warady BA, Zimmering M, Monteverde M, Testa S, Calyskan S, Drozdz D, Salusky I, Kemper MJ, Ekim M, Verrina E, Misselwitz J, Schaefer F (2008) Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis 51:455–462CrossRefPubMed Zurowska A, Feneberg R, Warady BA, Zimmering M, Monteverde M, Testa S, Calyskan S, Drozdz D, Salusky I, Kemper MJ, Ekim M, Verrina E, Misselwitz J, Schaefer F (2008) Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis 51:455–462CrossRefPubMed
10.
Zurück zum Zitat Vonesh EF (1991) Which statistical method to use when analyzing the incidence of peritoneal dialysis related infections? Perit Dial Int 11:301–304PubMed Vonesh EF (1991) Which statistical method to use when analyzing the incidence of peritoneal dialysis related infections? Perit Dial Int 11:301–304PubMed
11.
Zurück zum Zitat Zent R, Myers JE, Donald D, Rayner BL (1994) Continuous ambulatory peritoneal dialysis: an option in the developing world? Perit Dial Int 14:48–51PubMed Zent R, Myers JE, Donald D, Rayner BL (1994) Continuous ambulatory peritoneal dialysis: an option in the developing world? Perit Dial Int 14:48–51PubMed
12.
Zurück zum Zitat Grunberg J, Verocay MC, Rebori A, Ramela V, Amaral C, Hekimian G, Viera M, Pouso J (2005) Twenty years' pediatric chronic peritoneal dialysis in Uruguay: patient and technique survival. Pediatr Nephrol 20:1315–1319CrossRefPubMed Grunberg J, Verocay MC, Rebori A, Ramela V, Amaral C, Hekimian G, Viera M, Pouso J (2005) Twenty years' pediatric chronic peritoneal dialysis in Uruguay: patient and technique survival. Pediatr Nephrol 20:1315–1319CrossRefPubMed
13.
Zurück zum Zitat Ariza M, Lopez M, Quesada T (1991) Complications of CAPD in children: six years experience in Caracas, Venezuela. Adv Perit Dial 7:269–271PubMed Ariza M, Lopez M, Quesada T (1991) Complications of CAPD in children: six years experience in Caracas, Venezuela. Adv Perit Dial 7:269–271PubMed
14.
Zurück zum Zitat Graffar M (1956) Une methode de classification sociale d'echantillons de population. Courrier 332:133–138 Graffar M (1956) Une methode de classification sociale d'echantillons de population. Courrier 332:133–138
15.
Zurück zum Zitat Boehm M, Vecsei A, Aufricht C, Mueller T, Csaicsich D, Arbeiter K (2005) Risk factors for peritonitis in pediatric peritoneal dialysis: a single-center study. Pediatr Nephrol 20:1478–1483CrossRefPubMed Boehm M, Vecsei A, Aufricht C, Mueller T, Csaicsich D, Arbeiter K (2005) Risk factors for peritonitis in pediatric peritoneal dialysis: a single-center study. Pediatr Nephrol 20:1478–1483CrossRefPubMed
16.
Zurück zum Zitat Furth SL, Donaldson LA, Sullivan EK, Watkins SL (2000) Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 15:179–182CrossRefPubMed Furth SL, Donaldson LA, Sullivan EK, Watkins SL (2000) Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 15:179–182CrossRefPubMed
17.
Zurück zum Zitat Schaefer F, Klaus G, Muller-Wiefel DE, Mehls O (1999) Current practice of peritoneal dialysis in children: results of a longitudinal survey. Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS). Perit Dial Int 19[Suppl 2]:S445–S449PubMed Schaefer F, Klaus G, Muller-Wiefel DE, Mehls O (1999) Current practice of peritoneal dialysis in children: results of a longitudinal survey. Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS). Perit Dial Int 19[Suppl 2]:S445–S449PubMed
18.
Zurück zum Zitat Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC (2004) Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 44:591–603PubMed Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC (2004) Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis 44:591–603PubMed
19.
Zurück zum Zitat Hoshii S, Wada N, Honda M (2006) A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD. Pediatr Nephrol 21:828–834CrossRefPubMed Hoshii S, Wada N, Honda M (2006) A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD. Pediatr Nephrol 21:828–834CrossRefPubMed
20.
Zurück zum Zitat Auron A, Simon S, Andrews W, Jones L, Johnson S, Musharaf G, Warady BA (2007) Prevention of peritonitis in children receiving peritoneal dialysis. Pediatr Nephrol 22:578–585CrossRefPubMed Auron A, Simon S, Andrews W, Jones L, Johnson S, Musharaf G, Warady BA (2007) Prevention of peritonitis in children receiving peritoneal dialysis. Pediatr Nephrol 22:578–585CrossRefPubMed
21.
Zurück zum Zitat Warady BA, Feneberg R, Verrina E, Flynn JT, Muller-Wiefel DE, Besbas N, Zurowska A, Aksu N, Fischbach M, Sojo E, Donmez O, Sever L, Sirin A, Alexander SR, Schaefer F (2007) Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol 18:2172–2179CrossRefPubMed Warady BA, Feneberg R, Verrina E, Flynn JT, Muller-Wiefel DE, Besbas N, Zurowska A, Aksu N, Fischbach M, Sojo E, Donmez O, Sever L, Sirin A, Alexander SR, Schaefer F (2007) Peritonitis in children who receive long-term peritoneal dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol 18:2172–2179CrossRefPubMed
22.
Zurück zum Zitat Akpolat T (2009) Tuberculous peritonitis. Perit Dial Int 29[Suppl 2]:S166–S169PubMed Akpolat T (2009) Tuberculous peritonitis. Perit Dial Int 29[Suppl 2]:S166–S169PubMed
23.
Zurück zum Zitat Ferrara E, Lemire J, Grimm PC, Reznik VM, Mendoza SA, Leake JA, Benador NM (2004) Mycobacterial peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol 19:114–117CrossRefPubMed Ferrara E, Lemire J, Grimm PC, Reznik VM, Mendoza SA, Leake JA, Benador NM (2004) Mycobacterial peritonitis in pediatric peritoneal dialysis patients. Pediatr Nephrol 19:114–117CrossRefPubMed
Metadaten
Titel
Peritonitis in children on peritoneal dialysis in Cape Town, South Africa: epidemiology and risks
verfasst von
Renske Raaijmakers
Priya Gajjar
Cornelis Schröder
Peter Nourse
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 10/2010
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-010-1592-0

Weitere Artikel der Ausgabe 10/2010

Pediatric Nephrology 10/2010 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.